Treatment Efficacy

Roivant Halts namilumab development after trial setback

Abivax's Obefazimod shows promise in ulcerative colitis maintenance study

FDA approves AstraZeneca's Tagrisso for stage III non-small cell lung cancer

4D Molecular Therapeutics unveils promising data in wet AMD trial

GSK's HPV vaccine trial falls short of primary target

Summit Therapeutics surges after lung cancer trial success

PRAXIS (NASDAQ:PRAX) announces promising relutrigine study results

Amplia Therapeutics (ASX:ATX) reports results in Phase 2a ACCENT trial

Immutep's (ASX:IMM) combination therapy shows efficacy in head and neck cancer trial

Nurix Therapeutics (NASDAQ:NRIX) shines with NX-5948 trial data